1st drug OK'd for movement disorder caused by certain meds
April 12, 2017
TRENTON, N.J. (AP) — U.S. regulators have approved the first drug for treating a neurological syndrome that causes uncontrollable body movements that can also interfere with speech, swallowing and breathing.
The sometimes-disabling disorder, tardive dyskinesia, is caused by some widely used prescription medicines for psychiatric and gastrointestinal disorders. It can surface while patients are on those medicines or years after they stop. It affects about 500,000 U.S. patients.
The Food and Drug Administration on Tuesday approved Ingrezza, developed by Neurocrine Biosciences, for treating...